A 35-year-old male with cystic fibrosis presents with chronic productive cough, dyspnea, and recurrent respiratory infections. Sputum culture repeatedly grows mucoid, oxidase-positive, gram-negative rods. What is the most common cause of progressive lung disease and mortality in cystic fibrosis patients?

Explanation

## Pseudomonas aeruginosa in Cystic Fibrosis **Key Point:** Pseudomonas aeruginosa is the most common and most clinically significant pathogen in cystic fibrosis, responsible for the majority of respiratory morbidity and mortality in CF patients. ### Why P. aeruginosa Dominates in CF? **High-Yield:** CF patients have impaired mucociliary clearance and abnormal airway secretions that create an ideal environment for P. aeruginosa colonization and chronic biofilm formation: - Thick, viscous secretions trap bacteria - Reduced airway clearance allows persistent colonization - Biofilm formation protects bacteria from antibiotics and immune defenses - Mucoid phenotype (alginate capsule) is characteristic of CF isolates ### Pathogenic Features in CF | Feature | Significance | |---------|-------------| | Mucoid phenotype | Alginate overproduction; indicates chronic infection | | Biofilm formation | Antibiotic resistance; difficult to eradicate | | Exotoxin A production | Tissue damage; impairs immune response | | Elastase secretion | Destroys lung elastin; progressive bronchiectasis | | Chronic infection | Present in 80% of CF patients by age 18 | **Clinical Pearl:** The isolation of mucoid P. aeruginosa from CF sputum is a clinical milestone indicating transition from intermittent to chronic infection. This is associated with accelerated lung function decline and poorer prognosis. Early aggressive treatment with anti-pseudomonal antibiotics (inhaled tobramycin, azithromycin) is recommended to delay or prevent chronic colonization. **Mnemonic — CF + P. aeruginosa = **BIOFILM**:** Biofilm formation, Impaired clearance, Oxidase-positive, Filamentous morphology, Infections chronic, Lung damage, Mucoid phenotype.